Publication date: Dec 18, 2024
Diabetic eye disease, namely diabetic retinopathy (DR), remains a leading cause of preventable blindness worldwide. Research has shown that treatment for diabetes and eye care was disrupted during the pandemic – with disparities between urban and rural populations being unknown. Thus, we aimed to assess the prevalence of reported rates of DR and dilated fundus exams from 2017 to 2021. We performed a cross-sectional analysis using data from the Behavioral Risk Factor Surveillance System (BRFSS). Among US residents with diabetes, we calculated the rates of DR and annual dilated fundus exams – overall and by metropolitan statistical area (MSA) – measuring differences using X tests. In 2017, the rate of DR was 19. 78% among US residents reporting diabetes, which increased to the highest rate in 2018 at 22. 19% before dropping to the lowest rates in 2019 and 2020 (18. 44%). These annual changes were statistically significant (p
Concepts | Keywords |
---|---|
Diabetes | COVID-19 |
Ophthalmic | diabetes |
Rural | diabetic retinopathy |
Surveillance |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Diabetic Retinopathy |
disease | MESH | eye disease |
disease | MESH | blindness |
disease | MESH | COVID-19 |